Immunization with tumor cells, modified to secrete immune-augmenting cytokines such as IL-2, IFN-γ and GM-CSF, has resulted in the development of generalized MHC-restricted anti-tumor immune responses in animal models [20,21,22,23,24,25,26,27,28]. Here, IL2 is linked to neoplasm.